ASH: Anti - CD19 CAR T - Cell Tx Beneficial in B - Cell Lymphomas

Second study shows benefit in relapsed or refractory B - cell lymphoma, follicular lymphoma
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Oncology, Pharmacy, Conference News, Source Type: news